Research NewsScience Publishing

Prepaper Publicity Ignites Race to Publish

Science  28 Mar 1997:
Vol. 275, Issue 5308, pp. 1877
DOI: 10.1126/science.275.5308.1877

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

In late January, the biotech firm Myriad Genetics put out a press release announcing the discovery of a new tumor suppressor. The company took the step to forestall possible charges of insider trading by company employees, but it also had another effect: triggering an intense effort by a competing group to get its own discovery of the gene into print.

Related Content